Patents by Inventor Weldon Courtney McGregor

Weldon Courtney McGregor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition
    Patent number: 6255284
    Abstract: Polypeptide pharmaceutical compositions having improved stability and resistance to aggregation, particle formation and precipitation comprising a polypeptide pharmaceutical and poloxamer surfactants alone, or in combination with polysorbate surfactants. Preferred polypeptides stabilized are bactericidal/permeability increasing (BPI) protein, biologically active fragments of BPI, biologically active analogs of BPI, and biologically active variants of BPI.
    Type: Grant
    Filed: February 11, 2000
    Date of Patent: July 3, 2001
    Assignee: Xoma Corporation
    Inventors: Weldon Courtney McGregor, James Stubstad, C. Paul Chang
  • Pharmaceutical compositions of bactericidal/permeability increasing protein (BPI)
    Patent number: 6066620
    Abstract: Polypeptide pharmaceutical compositions having improved stability and resistance to aggregation, particle formation and precipitation comprising a polypeptide pharmaceutical and poloxamer surfactants alone, or in combination with polysorbate surfactants. Preferred polypeptides stabilized are bactericidal/permeability increasing (BPI) protein, biologically active fragments of BPI, biologically active analogs of BPI, and biologically active variants of BPI.
    Type: Grant
    Filed: May 17, 1999
    Date of Patent: May 23, 2000
    Assignee: Xoma Corporation
    Inventors: Weldon Courtney McGregor, James Stubstad, C. Paul Chang
  • Pharmaceutical composition
    Patent number: 5955427
    Abstract: Polypeptide pharmaceutical compositions having improved stability and resistance to aggregation, particle formation and precipitation comprising a polypeptide pharmaceutical and poloxamer surfactants alone, or in combination with polysorbate surfactants. Preferred polypeptides stabilized are bactericidal/permeability increasing (BPI) protein, biologically active fragments of BPI, biologically active analogs of BPI, and biologically active variants of BPI.
    Type: Grant
    Filed: December 8, 1997
    Date of Patent: September 21, 1999
    Assignee: XOMA Corporation
    Inventors: Weldon Courtney McGregor, James Stubstad, C. Paul Chang
  • Pharmaceutical composition
    Patent number: 5696090
    Abstract: Polypeptide pharmaceutical compositions having improved stability and resistance to aggregation, particle formation and precipitation comprising a polypeptide pharmaceutical and poloxamer surfactants alone, or in combination with polysorbate surfactants. Preferred polypeptides stabilized are bactericidal/permeability increasing (BPI) protein, biologically active fragments of BPI, biologically active analogs of BPI, and biologically active variants of BPI.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 9, 1997
    Assignee: Xoma Corporation
    Inventors: Weldon Courtney McGregor, James Stubstad, C. Paul Chang
  • Stabilized thymosin composition and method
    Patent number: 4082737
    Abstract: Thymosin fraction 5 has been widely employed recently in the clinical investigation of this thymic hormone. This material is a hormonally active proteinaceous composition which is involved in the regulation of cell-mediated immunity. The present disclosure provides a solid, stable, endotoxin and pyrogen free thymosin fraction 5 composition suitable for reconstitution for injection.
    Type: Grant
    Filed: February 22, 1977
    Date of Patent: April 4, 1978
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Weldon Courtney McGregor, Harold Leon Newmark, Armin Hermann Ramel